Angelika Jahreis M.D.

Angelika Jahreis MD, PhD, is a board-certified dermatologist with extensive experience in immunology and drug development. Currently serving as a Board Member at Agomab since October 2023, and as SVP Global Head of Development Immunology at Novartis since September 2020, Angelika has also held leadership roles at Gilead Sciences, Genentech, Amgen, and Schering Ag (now Bayer). Angelika's academic background includes a residency and fellowship in dermatology from the University of Leipzig, coupled with an MD/PhD in Medicine/Immunology from the University of Freiburg, Heidelberg, and Erlangen. Angelika's career reflects a strong commitment to advancing medical science and treatment options in dermatology and immunology.